Clinical Trials Logo

Stress Disorders, Traumatic clinical trials

View clinical trials related to Stress Disorders, Traumatic.

Filter by:

NCT ID: NCT03045016 Completed - Clinical trials for Acute Stress Disorder

Efficacy of Prazosin in Preventing Post-traumatic Stress Disorder

PRAZOSTRESS
Start date: April 21, 2017
Phase: Phase 2
Study type: Interventional

After a traumatic event such as an accident or an assault, victims may experience intense stress symptoms that may evolve into "post-traumatic stress disorder" (PTSD). It is a frequent and serious pathology, which can be complicated by depression, addiction or suicide. Few means are available to prevent PTSD in people who have just undergone trauma. Prazosin is an antihypertensive drug that blocks α1 adrenaline receptors which could help to stop the vicious circle of stress and prevent the development of the disease. The objective of this study is to demonstrate the efficacy of prazosin to prevent PTSD in patients who visit an emergency department after trauma.

NCT ID: NCT03039231 Completed - Clinical trials for Stress Disorders, Post-Traumatic

Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD)

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

This study will test the efficacy of the Freespira Breathing System in adults with post traumatic stress disorder (PTSD).

NCT ID: NCT03033069 Completed - Clinical trials for Stress Disorders, Post-Traumatic

A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)

Start date: January 26, 2017
Phase: Phase 2
Study type: Interventional

To evaluate the safety, efficacy and tolerability of brexpiprazole (with placebo) as monotherapy or combination therapy with Zoloft (sertraline) in adults with PTSD.

NCT ID: NCT03019497 Completed - PTSD Clinical Trials

Cognitive-behavioral Therapy for Treatment of Post-traumatic Stress Disorder and Related Problems

CBT-PTSD-RP
Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of a form of cognitive behavioral therapy (CBT) in a population of individuals with PTSD and common related problems (depression, anxiety or sleep disorders, pain, psychosocial stressors, low social support, substance use disorder). Half of the participants will receive a cognitive behavioral therapy with specific modules for the treatment of related problems (CBT-E) and the other half of participants will receive therapy without specific modules (CBT-C). The main assumption is that participants treated in the CBT-E condition will present a lower level of symptom intensity of PTSD and a higher remission rate than those in the CBT-C condition during the post-treatment assessment. As a secondary objective, an analysis of the different parameters of effectiveness of the two forms of CBT (e.g., average number of sessions required to reach remission, treatment strategies used) will be performed.

NCT ID: NCT02992899 Completed - Clinical trials for PostTraumatic Stress Disorder

Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder

Start date: April 19, 2017
Phase: Phase 3
Study type: Interventional

The tasks of the project are to map the potency and kinetics of the neurologic, autonomic peripheral, inflammatory, and behavioral responses to vagal nerve stimulation (VNS) vs. sham treatment, at baseline and in response to stressful traumatic scripts related to personal traumatic events, as well as a series of other stressors.

NCT ID: NCT02990793 Recruiting - Clinical trials for Traumatic Brain Injury

Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

MeRT-005-B
Start date: April 4, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder

NCT ID: NCT02966873 Completed - Alcohol Abuse Clinical Trials

Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)

Start date: October 1, 2016
Phase: Phase 2
Study type: Interventional

This is a randomized controlled Phase II clinical trial designed to evaluate the effects of N-acetylcysteine (NAC) in reducing Alcohol Use Disorder (AUD) severity and Post Traumatic Stress Disorder (PTSD) symptomatology among individuals with current AUD and PTSD.

NCT ID: NCT02956902 Completed - Clinical trials for PostTraumatic Stress Disorder

A Smartphone Intervention With Telemedicine Support for Management of Post-traumatic Stress Disorder: A Randomized Trial

Start date: December 2016
Phase: N/A
Study type: Interventional

This study tests whether people receiving clinician support to use a mobile application on their smartphone can manage their post-traumatic stress disorder (PTSD) symptoms better than those who do not. Half of the participants will receive the clinician supported smartphone application intervention and the other half will remain on the waiting list.

NCT ID: NCT02954146 Completed - Clinical trials for Posttraumatic Stress Disorder

Mobile Health Application for Family and Behavioral Health Provider Communication

Start date: November 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to examine feasibility, tolerability, utilization, and effectiveness of using the SupportTeam mobile application in the context of Cognitive Behavioral Therapy (CBT) for veterans with PTSD.

NCT ID: NCT02950961 Completed - Depression Clinical Trials

Collaborative Care for Women Veterans

CCWV
Start date: June 30, 2017
Phase: N/A
Study type: Interventional

Implementation of Tailored Collaborative Care for Women Veterans (CCWV) was designed to enhance primary care-mental health integration for women Veterans by tailoring services to women Veterans' and providers' needs and providing an evidence-based intervention, Coordinated Anxiety Learning and Management, to address anxiety and depression in a patient-centered approach. CCWV was implemented in two of the Women's Health Practice-Based Research Network sites, with careful attention to local tailoring and adaptation to enhance the fit of the care model in varied local contexts.